Lu Alleruzzo, CEO; Tomas Hode, CIO & President; and the Immunophotonics Team want to congratulate Dr. Wei Chen on being elected to the American Institute of Medical and Biological Engineering (AIMBE) College of Fellows for his outstanding contributions to the invention, development, translation, and commercialization of laser immunotherapy for the treatment of metastatic cancers.

This is a well-deserved recognition for Dr. Chen whose research focuses on novel cancer therapies and on immunologically modified nanoplatform for cancer treatment using nano-photo-immuno effects. He has published 170+ peer-reviewed articles (with an h-index of 53). He has been awarded 10 US patents and multiple international patents.